Literature DB >> 21606176

The affinity of D2-like dopamine receptor antagonists determines the time to maximal effect on cocaine self-administration.

Andrew B Norman1, Michael R Tabet, Mantana K Norman, Brittney K Fey, Vladimir L Tsibulsky, Ronald W Millard.   

Abstract

Differences in the time to maximal effect (T(max)) of a series of dopamine receptor antagonists on the self-administration of cocaine are not consistent with their lipophilicity (octanol-water partition coefficients at pH 7.4) and expected rapid entry into the brain after intravenous injection. It was hypothesized that the T(max) reflects the time required for maximal occupancy of receptors, which would occur as equilibrium was approached. If so, the T(max) should be related to the affinity for the relevant receptor population. This hypothesis was tested using a series of nine antagonists having a 2500-fold range of K(i) or K(d) values for D(2)-like dopamine receptors. Rats self-administered cocaine at regular intervals and then were injected intravenously with a dose of antagonist, and the self-administration of cocaine was continued for 6 to 10 h. The level of cocaine at the time of every self-administration (satiety threshold) was calculated throughout the session. The satiety threshold was stable before the injection of antagonist and then increased approximately 3-fold over the baseline value at doses of antagonists selected to produce this approximately equivalent maximal magnitude of effect (maximum increase in the equiactive cocaine concentration, satiety threshold; C(max)). Despite the similar C(max), the mean T(max) varied between 5 and 157 min across this series of antagonists. Furthermore, there was a strong and significant correlation between the in vivo T(max) values for each antagonist and the affinity for D(2)-like dopamine receptors measured in vitro. It is concluded that the cocaine self-administration paradigm offers a reliable and predictive bioassay for measuring the affinity of a competitive antagonist for D(2)-like dopamine receptors.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21606176      PMCID: PMC3141900          DOI: 10.1124/jpet.111.183244

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  23 in total

1.  Satiety threshold: a quantitative model of maintained cocaine self-administration.

Authors:  V L Tsibulsky; A B Norman
Journal:  Brain Res       Date:  1999-08-21       Impact factor: 3.252

2.  The compulsion zone: a pharmacological theory of acquired cocaine self-administration.

Authors:  Andrew B Norman; Vladimir L Tsibulsky
Journal:  Brain Res       Date:  2006-08-30       Impact factor: 3.252

3.  Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs.

Authors:  I Creese; D R Burt; S H Snyder
Journal:  Science       Date:  1976-04-30       Impact factor: 47.728

4.  Extracellular cocaine and dopamine concentrations are linearly related in rat striatum.

Authors:  L C Nicolaysen; H T Pan; J B Justice
Journal:  Brain Res       Date:  1988-07-26       Impact factor: 3.252

5.  Quantification of R-(+)-7-chloro-8-hydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-methyl-3- benzazepine in brain and blood by use of reversed-phase high-performance liquid chromatography with electrochemical detection.

Authors:  C D Kilts; K L Dew; T D Ely; R B Mailman
Journal:  J Chromatogr       Date:  1985-08-09

6.  Competitive dopamine receptor antagonists increase the equiactive cocaine concentration during self-administration.

Authors:  Andrew B Norman; Mantana K Norman; Michael R Tabet; Vladimir L Tsibulsky; Amadeo J Pesce
Journal:  Synapse       Date:  2010-10-08       Impact factor: 2.562

7.  Classification of substrates and inhibitors of P-glycoprotein using unsupervised machine learning approach.

Authors:  Yong-Hua Wang; Yan Li; Sheng-Li Yang; Ling Yang
Journal:  J Chem Inf Model       Date:  2005 May-Jun       Impact factor: 4.956

8.  Interactions of agonists with D-2 dopamine receptors: evidence for a single receptor population existing in multiple agonist affinity-states in rat striatal membranes.

Authors:  M W Hamblin; S E Leff; I Creese
Journal:  Biochem Pharmacol       Date:  1984-03-15       Impact factor: 5.858

9.  Critical reevaluation of spiperone and benzamide binding to dopamine D2 receptors: evidence for identical binding sites.

Authors:  A Malmberg; E Jerning; N Mohell
Journal:  Eur J Pharmacol       Date:  1996-05-06       Impact factor: 4.432

10.  Quantification of SCH 39166, a novel selective D1 dopamine receptor antagonist, in rat brain and blood.

Authors:  J Hietala; T Seppäla; J Lappalainen; E Syvälahti
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

View more
  4 in total

Review 1.  Neurobiology of addiction: a neurocircuitry analysis.

Authors:  George F Koob; Nora D Volkow
Journal:  Lancet Psychiatry       Date:  2016-08       Impact factor: 27.083

2.  Differential effects of acute and chronic antagonist and an irreversible antagonist treatment on cocaine self-administration behavior in rats.

Authors:  Hanna N Wetzel; Vladimir L Tsibulsky; Andrew B Norman
Journal:  Sci Rep       Date:  2022-05-24       Impact factor: 4.996

3.  Stimulant-induced dopamine increases are markedly blunted in active cocaine abusers.

Authors:  N D Volkow; D Tomasi; G-J Wang; J Logan; D L Alexoff; M Jayne; J S Fowler; C Wong; P Yin; C Du
Journal:  Mol Psychiatry       Date:  2014-06-10       Impact factor: 15.992

Review 4.  Molecular Imaging of Opioid and Dopamine Systems: Insights Into the Pharmacogenetics of Opioid Use Disorders.

Authors:  Jamie A Burns; Danielle S Kroll; Dana E Feldman; Christopher Kure Liu; Peter Manza; Corinde E Wiers; Nora D Volkow; Gene-Jack Wang
Journal:  Front Psychiatry       Date:  2019-09-18       Impact factor: 4.157

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.